News
Brief news reports on Tuberculosis
By
Médecins Sans Frontières
Published: Nov. 20, 2013, 4:57 p.m.·
Tags:
None
NEW YORK, November 19, 2013 – At the first meeting of Trans-Pacific Partnership (TPP) negotiators since the intellectual property chapter of the secret trade agreement was leaked last week, Doctors Without Borders/Médecins Sans Frontières (MSF) urges countries to stand strong against the attack on access to affordable medicines.
Read More →
Published: Nov. 17, 2013, 5:55 p.m.·
Tags:
None
Jigna Rao, patient advocate, speaks about patient centered approaches to cure at the TAG symposium “Cascades: Improving TB Care”, held on November 1 during the 2013 Union World Conference on Lung Health in Paris, France.
Read More →
By
Business Standard
Published: Nov. 16, 2013, 5:47 p.m.·
Tags:
None
In more bad news for people diagnosed with diabetes, the lifestyle disease has now been linked to an increased incidence of tuberculosis (TB) in patients.
Read More →
By
P. T. Jyothi Datta
Published: Nov. 16, 2013, 5:41 p.m.·
Tags:
None
Mumbai, Nov. 13: Drug-maker Sandoz has been asked to recall a batch of wrongly-packaged tuberculosis (TB) drugs from the market. The incorrect packaging was first discovered in Mumbai and the recall will cover five States.
Read More →
By
TB Europe Coalition
Published: Nov. 16, 2013, 5:32 p.m.·
Tags:
None
On 13th November, the Global Fund Secretariat organised a consultation at WHO Europe headquarters in Copenhagen to define a regional TB strategy for the implementation of its New Funding Model (NFM) in Eastern Europe and Central Asia (EECA).
Read More →
By
TuBerculosis Vaccine Initiative (TBVI)
Published: Nov. 16, 2013, 5:09 p.m.·
Tags:
None
A phase I safety study of TB vaccine candidate MTBVAC, the first live-attenuated Mycobacterium tuberculosis-based vaccine to enter clinical trials, shows very good results in the first intermediate analysis. Although the study is not finished yet, the 36 volunteers did not show any signs of disease or side effects so far. “In my experience, it is one of the safest vaccines ever tested,” says Professor François Spertini of the University Hospital of Lausanne (CHUV) in Switzerland, the Principal Investigator of the trial. “But a further nine months of investigation is necessary to further validate safety and ascertain whether the vaccine is also effective.”
Read More →
By
Stop TB Partnership
Published: Nov. 16, 2013, 4:52 p.m.·
Tags:
None
12 November 2013 - Kabul, Afghanistan - A fire that destroyed the entire stock of tuberculosis (TB) drugs in Afghanistan’s central warehouse threatened to leave TB patients in the country without the medicines needed to continue their treatment. But local and international partners rallied around the national TB programme to provide a swift emergency response.
Read More →
By
R. Prasad
Published: Nov. 16, 2013, 4:14 p.m.·
Tags:
None
A body of evidence clearly points out that children aged under five years are at-risk group for getting infected with TB and developing disease very soon after infection. And the severe forms of the disease — disseminated TB and meningitis — afflict the young ones.
Read More →
By
R. Prasad
Published: Nov. 16, 2013, 3:15 p.m.·
Tags:
None
Prof Peter R. Donald, Emeritus Professor in the Department of Paediatrics and Child Health of the Faculty of Health Sciences at Stellenbosch University, South Africa was awarded the highest honour, the Union Medal, of the International Union Against Tuberculosis and Lung Disease, at the 2010 General Assembly in Berlin.
Read More →
By
Mara Kardas-Nelson
Published: Nov. 16, 2013, 3:01 p.m.·
Tags:
None
Increasing the daily dose of rifampicin within the current TB treatment regimen from 10mg/kg to 15mg/kg and 20mg/kg did not result in an increased incidence of adverse events, according to findings from the RIFATOX trial presented at the 44th World Conference on Lung Health in Paris earlier this month.
Read More →
Page 685 of 878 · Total posts: 10
←First
684
685
686
Last→